National Agency for Food and Drug Administration and Control NAFDAC has alerted Nigerians, particularly healthcare providers, to one batch of counterfeit Meronem 1g Injection being purchased in Nigeria.
The information signed by the Director General of the agency, Mojisola Adeyeye, and issued to Newsmen in Abuja on Tuesday.
Adeyeye said the Marketing Authorization Holder MAH Pfizer, reported the incident, as received through a patient notification platform, concerning a suspicious park of Meronem 1g injection purchase.
She reported Pfizer as saying that the vial content did not dissolve when reconstituted for use and that further visual inspection of the pack was observed.
The D-G said that the production process did not meet with the Pfizer’s specifications.
The NAFDAC boss, however, said that healthcare providers and patients were advised to obtain all medical products from authorised/licensed suppliers.